Journals of Gerontology Series A: Biological Sciences and Medical Sciences Large Type Edition
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]
Author:
Keyword(s):
Year:  Vol:  Page: 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Cited by other online articles
Google Scholar
Right arrow Articles by Aronow, W. S.
Right arrow Articles citing this Article
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aronow, W. S.
The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 59:1173-1185 (2004)
© 2004 The Gerontological Society of America

Management of the Elderly Person After Myocardial Infarction

Wilbert S. Aronow

Divisions of Cardiology and Geriatrics, Department of Medicine, New York Medical College, Valhalla.

Address correspondence to Wilbert S. Aronow, MD, Cardiology Division, New York Medical College, Macy Pavilion, Rm. 138, Valhalla, NY 10595. E-mail: wsaronow{at}aol.com

Elderly persons after myocardial infarction should have their modifiable coronary artery risk factors intensively treated. Hypertension should be treated with beta blockers and angiotensin-converting enzyme inhibitors. The blood pressure should be reduced to <140/85 mmHg and to ≥130/80 mmHg in persons with diabetes or renal insufficiency. The serum low-density lipoprotein cholesterol should be reduced to <100 mg/dl with statins if necessary. Aspirin or clopidogrel, beta blockers, and angiotensin-converting enzyme inhibitors should be given indefinitely unless contraindications exist to the use of these drugs. Long-acting nitrates are effective antianginal and antiischemic drugs. There are no Class I indications for the use of calcium channel blockers after myocardial infarction. Postinfarction patients should not receive Class I antiarrhythmic drugs, sotalol, or amiodarone. An automatic implantable cardioverter-defibrillator should be implanted in postinfarction patients at very high risk for sudden cardiac death. Hormonal therapy should not be used in postmenopausal women after myocardial infarction. The two indications for coronary revascularization are prolongation of life and relief of unacceptable symptoms despite optimal medical management.




This article has been cited by other articles: (Search Google Scholar for Other Citing Articles)


Home page
J Public Health (Oxf)Home page
S. E. Ramsay, R. W. Morris, O. Papacosta, L. T. Lennon, M. C. Thomas, and P. H. Whincup
Secondary prevention of coronary heart disease in older British men: extent of inequalities before and after implementation of the National Service Framework
J. Public Health Med., December 1, 2005; 27(4): 338 - 343.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
R. Fleetcroft and N. Steel
Secondary prevention of heart disease with statins: Findings are unexpected
BMJ, May 21, 2005; 330(7501): 1208 - 1208.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
All GSA journals The Gerontologist
Journals of Gerontology Series B: Psychological Sciences and Social Sciences
Copyright © 2004 by The Gerontological Society of America.